Shockwave Medical (SWAV) Tops Q3 EPS by 14c

Shockwave Medical (NASDAQ: SWAV) reported Q3 EPS of $0.92, $0.14 better than the analyst estimate of $0.78. Revenue for the quarter came in at $186.02 million versus the consensus estimate of $184.72 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• SuperCom (SPCB) Tops Q3 EPS by 43c